← Back to Vaccine Database

ABNCoV2

Virus-like particle vaccine · VDDBV0027

Target & Classification

SARS-CoV-2SARS-CoV-2
Virus-like particle vaccine
Covid19; Severe Acute Respiratory Syndrome
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04839146 Phase 1Covid19; Severe Acute Respiratory Syndrome